Cellares
Accelerating Access to Life-Saving Cell Therapies
327 employees · est. 2019 · South San Francisco, United...
Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.
925 employees · est. 2007 · San Carlos, United States
Iovance Biotherapeutics, Inc. is the older company (2019 vs 2007); Iovance Biotherapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Cellares | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2007 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | San Carlos, United States |
| Employees | ||
| Employees | 327 | 925 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series D | IPO |
| Total Funding | ||
| Total Funding | $612.00M | $1.78B |
| Funding Rounds | ||
| Funding Rounds | 4 | 10 |
| Services | ||
| Services | Cell Shuttle® Platform, Cell Q™ Platform, Clinical & Commercial Manufacturing, Analytical Method Automation, Process Automation, Quality and Regulatory Consultation | TIL Therapy Development, Clinical Research, Manufacturing at Cell Therapy Center, Scientific Publications & Presentations, Pipeline Development for Advanced Solid Tumor Cancers |
| Target Customers | ||
| Target Customers | Biopharmaceutical Companies, Cell Therapy Developers, Pharmaceutical Companies | Patients with Advanced Solid Tumor Cancers, Healthcare Providers, Clinical Researchers, Pharmaceutical Investors |
| Taxonomy | ||
| Taxonomy | Integrated Development And Manufacturing Organization, Cell Therapy, Industry 4.0, Automated Manufacturing, Cell Shuttle, Cell Q, Smart Factories, Advanced Manufacturing Technology, FDA Compliance, Oncology, Autoimmune Indications, Clinical Manufacturing, Process Automation, Scalable Manufacturing, Cost Reduction | Patient-Centric Organization, Cancer Treatment Innovation, Tumor Infiltrating Lymphocytes (TIL) Therapy, Autologous T-Cell Treatment, Immunotherapy Development, Solid Tumor Focus, Gene-Edited Cell Therapy, Cell Therapy Manufacturing, Clinical Data Development, Regulatory Approval Preparation, San Francisco Bay Area Headquarters, Philadelphia Manufacturing Facility, Tampa Research Site, Commercial Launch Execution, Cancer Immunotherapy Commercialization |
| Website | ||
| Website | cellares.com | iovance.com |
About Cellares
Cellares, founded in 2019 and headquartered in the United States, is at the forefront of revolutionizing cell therapy manufacturing. As the first Integrated Development and Manufacturing Organization (IDMO), Cellares delivers on its promise of "Accelerating Access to Life-Saving Cell Therapies" by d...
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a biotechnology company founded in 2007 with a mission to revolutionize cancer treatment through its innovative tumor infiltrating lymphocyte (TIL) therapies. As a patient-centric organization, Iovance harnesses the human immune system's potential to target and elimi...
We will tell you when either one moves
BounceWatch watches Cellares and Iovance Biotherapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cellares and Iovance Biotherapeutic... — by email.
Frequently Asked Questions
Compare Cellares with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cellares on 15 Jun 2026, and Iovance Biotherapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.